{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T06:06:57Z","timestamp":1778998017372,"version":"3.51.4"},"reference-count":51,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2018,7,8]],"date-time":"2018-07-08T00:00:00Z","timestamp":1531008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004836","name":"Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["4004\u201000234B"],"award-info":[{"award-number":["4004\u201000234B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec><jats:title>Aims<\/jats:title><jats:p>Some antipsychotics increase prolactin levels, which might increase the risk of breast cancer. Existing evidence is conflicting and based on sparse data, especially for the increasingly used second\u2010generation antipsychotics. We conducted a nationwide case\u2013control study of the association between antipsychotic use and incident breast cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>From the Danish Cancer Registry, we identified women with a first\u2010time diagnosis of breast cancer 2000\u20132015 (<jats:italic>n<\/jats:italic>\u00a0=\u00a060\u2009360). For each case, we age\u2010matched 10 female population controls. Using conditional logistic regression, we calculated odds ratios (ORs) for breast cancer associated with use of antipsychotics. We stratified antipsychotics by first\u2010 and second\u2010generation status and by ability to induce elevation of prolactin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 4951 cases (8.1%) and 47\u2009643 controls (7.9%) had ever used antipsychotics. Long\u2010term use (\u226510\u2009000\u00a0mg olanzapine equivalents) was associated with breast cancer, with an adjusted OR of 1.18 [95% confidence interval (CI), 1.06, 1.32]. A weak dose\u2013response pattern was seen, with ORs increasing to 1.27 (95% CI 1.01, 1.59) for \u226550\u2009000\u00a0mg olanzapine equivalents. Associations were similar for first\u2010 and second\u2010generation antipsychotics (ORs 1.17 <jats:italic>vs<\/jats:italic>. 1.11), but also for nonprolactin inducing\u2010antipsychotics (OR 1.17). Stratifying by oestrogen receptor status, positive associations were seen for oestrogen receptor\u2010positive cancers (long\u2010term use: OR 1.29; 95% CI 1.13, 1.47) while no associations were observed for oestrogen receptor\u2010negative cancers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Overall, our results do not suggest a clinically important association between antipsychotic use and risk of breast cancer. The importance of drug\u2010induced prolactin elevation is unclear but may lead to a slightly increased risk of oestrogen receptor\u2010positive breast cancer.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bcp.13661","type":"journal-article","created":{"date-parts":[[2018,6,2]],"date-time":"2018-06-02T06:58:45Z","timestamp":1527922725000},"page":"2152-2161","source":"Crossref","is-referenced-by-count":46,"title":["Use of antipsychotics and risk of breast cancer: a Danish nationwide case\u2013control study"],"prefix":"10.1111","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9314-5679","authenticated-orcid":false,"given":"Anton","family":"Potteg\u00e5rd","sequence":"first","affiliation":[{"name":"Clinical Pharmacology and Pharmacy, Department of Public Health University of Southern Denmark  Odense Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy L.","family":"Lash","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology Aarhus University  Aarhus Denmark"},{"name":"Department of Epidemiology, Rollins School of Public Health Emory University  Atlanta Georgia USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deirdre","family":"Cronin\u2010Fenton","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology Aarhus University  Aarhus Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas P.","family":"Ahern","sequence":"additional","affiliation":[{"name":"Departments of Surgery and Biochemistry, Larner College of Medicine University of Vermont  Burlington Vermont USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0591-7187","authenticated-orcid":false,"given":"Per","family":"Damkier","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry and Pharmacology Odense University Hospital  Odense Denmark"},{"name":"Department of Clinical Research University of Southern Denmark  Odense Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,7,8]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1596\/978-1-4648-0349-9_ch3"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/1010539513488795"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-2760(02)00603-3"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-008-9069-5"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13050650"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.11.043"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12459"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21203"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2826.2010.02011.x"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.3233\/BD-2003-18108"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/wdev.35"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-09-0253"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1210\/endo.138.12.5605"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI119820"},{"key":"e_1_2_8_16_1","first-page":"421","article-title":"The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review","volume":"28","author":"Peuskens J","year":"2014","journal-title":"CNS Drugs"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-0665"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0896"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29714"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2007.05.027"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10911-008-9063-y"},{"key":"e_1_2_8_22_1","first-page":"243","article-title":"Antipsychotic treatment, prolactin, and breast tumorigenesis","volume":"28","author":"De Hert M","year":"2016","journal-title":"Psychiatr Danub"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-1870"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/PRA.0000000000000085"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.9778\/cmajo.20140009"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.201200186"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1506-2"},{"key":"e_1_2_8_28_1","first-page":"535","article-title":"The Danish Cancer Registry \u2013 history, content, quality and use","volume":"44","author":"Storm HH","year":"1997","journal-title":"Dan Med Bull"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810393562"},{"key":"e_1_2_8_30_1","article-title":"Data Resource Profile: The Danish National Prescription Registry","author":"Potteg\u00e5rd A","year":"2017","journal-title":"Int J Epidemiol"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S91125"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810393563"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810395825"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810394715"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494811405098"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-014-9930-3"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494810387965"},{"key":"e_1_2_8_38_1","volume-title":"Modern epidemiology","author":"Rothman KJ","year":"2008"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2009.09060802"},{"key":"e_1_2_8_40_1","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology.Guidelines for ATC classification and DDD assignment 2016. Oslo 2016."},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4145"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-11-83"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-87959-8"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/1403494811399956"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1159\/000356498"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2003.10.008"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-09-0326"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1053\/ejso.2000.0943"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.59.12.1147"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603259"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a010091"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.13661","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.13661","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T11:33:05Z","timestamp":1695036785000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.13661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,8]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.1111\/bcp.13661"],"URL":"https:\/\/doi.org\/10.1111\/bcp.13661","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,8]]}}}